Cantor Fitzgerald reiterates Overweight on Strategy stock at $212 By Investing.com

Strategy (MSTR) reported a Q1 net loss and missed both EPS and revenue estimates, with EPS at -$38.25 versus -$18.98 expected and revenue of $124.3 million versus $125.07 million forecast. Cantor Fitzgerald reiterated an Overweight rating and $212 price target, noting the market likely priced in the miss and that management has multiple tools to protect liquidity, including equity/preferred issuance and possible Bitcoin sales. The company’s openness to selling Bitcoin marks a notable shift in capital allocation messaging, though management does not expect near-term sales.

Analysis

The key change is not the quarter itself; it is that management is effectively admitting the equity is now a funding currency of last resort rather than a pure balance-sheet wrapper around bitcoin. That matters because once the market believes dilution, preferred issuance, or even asset sales are all on the table, the stock starts trading less like a levered BTC proxy and more like a volatile hybrid of a closed-end fund and a credit story. In practice, that usually compresses multiple expansion on rallies and increases sensitivity to BTC drawdowns because investors begin discounting financing flexibility rather than only coin mark-to-market.

The second-order effect is on the capital structure, not the operating business. Any explicit willingness to sell bitcoin creates a soft floor under liquidity but a harder ceiling on narrative momentum: it reduces near-term insolvency risk while making future BTC accumulation less credible, which can pull in a more skeptical shareholder base and widen the gap between headline sentiment and the actual underwriting of the preferred stack. If bitcoin weakens over the next 1-3 months, the market may test whether this is a one-time rhetorical shift or the start of a forced de-risking cycle.

Consensus appears to be underpricing how quickly this can become reflexive. If BTC stays range-bound, the stock can grind higher on financing optionality and short-covering; if BTC breaks lower, the same optionality becomes a signal that the company is willing to monetize its core reserve asset, which would likely accelerate multiple compression. The asymmetry is poor for longs here unless they are explicitly expressing a view on BTC upside exceeding equity dilution risk over a multi-quarter horizon.

Key Decisions for Investors

• Short MSTR vs long BTC spot or BTC ETF for 1-3 months: isolates the equity-specific dilution/financing discount. Best if BTC remains range-bound; risk is a sharp BTC breakout that re-levers the equity.
• Buy MSTR downside via put spreads into any post-earnings strength, targeting a 30-60 day window. Structure for a controlled premium outlay because the stock can stay elevated on narrative flows, but the downside convexity improves if BTC rolls over.
• If already long BTC-beta, rotate part of that exposure from MSTR into BTC itself over the next 1-2 weeks. The equity now carries additional capital structure and governance risk that BTC does not.
• For event-driven traders, sell call spreads against long MSTR only if implied vol remains elevated above realized. This monetizes the story premium while limiting upside bleed if management continues to signal liquidity discipline.
• Do not add to outright MSTR longs unless your base case is BTC up materially over the next quarter. The stock’s risk/reward is now dominated by financing credibility, not just digital asset exposure.